Carlyle has agreed to pick up a significant minority stake in Ajay Piramal’s pharma business for $490 million trumping rival private equity peers KKR and TA Associates. The 20% stake sale values Piramal’s pharma business at Carlyle’s offer would value the business at around Rs 20,000 crore ($2.6 billion).
Cyril Amarchand Mangaldas acted for
AZB & Partners acted for steady client
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
threads most popular
thread most upvoted
comment newest
first oldest
first
threads most popular
thread most upvoted
comment newest
first oldest
first